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Abstract
Limbal epithelial stem cells may ameliorate limbal stem cell deficiency through secretion of therapeutic proteins, delivered
to the cornea in a controlled manner using hydrogels. In the present study the secretome of alginate-encapsulated limbal
epithelial stem cells is investigated. Conditioned medium was generated from limbal epithelial stem cells encapsulated in
1.2% (w/v) calcium alginate gels. Conditioned medium proteins separated by 1-D gel electrophoresis were visualized by
silver staining. Proteins of interest including secreted protein acidic and rich in cysteine, profilin-1, and galectin-1 were
identified by immunoblotting. The effect of conditioned medium (from alginate-encapsulated limbal epithelial stem cells)
on corneal epithelial cell proliferation was quantified and shown to significantly inhibit (P#0.05) their growth. As secreted
protein acidic and rich in cysteine was previously reported to attenuate proliferation of epithelial cells, this protein may be
responsible, at least in part, for inhibition of corneal epithelial cell proliferation. We conclude that limbal epithelial stem cells
encapsulated in alginate gels may regulate corneal epithelialisation through secretion of inhibitory proteins.
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Introduction
Damage to the limbal region of the cornea can reduce or
destroy the resident population of limbal epithelial stem cells
(LESC) responsible for replenishing the corneal epithelium,
consequently leading to limbal stem cell deficiency (LSCD) [1–
2], and persistent epithelial defects resulting in visual loss and
blindness. An established therapy for LSCD involves the
transplantation of LESC expanded ex vivo on a human amniotic
membrane (AM) carrier [2–7]. The outcomes from this therapy
are, however, variable and due to lengthy pre-clinical manufac-
turing procedures, requiring specialised GMP facilities, it is
economically costly to generate therapeutic LESC. Therefore,
there is a need to refine current therapy for LSCD to enhance
clinical predictability, practicability and economic viability.
Understanding the mechanisms by which LESC repair the
damaged cornea is possible using hydrogel matrices as cell-
encapsulation devices. Furthermore, these constructs may allow
significant improvements in the treatment of LSCD by reducing
the length of pre-clinical procedures and allowing controlled
release of factors secreted from immobilized LESC to the injured
cornea. The premise of the present study is that alginate-
encapsulated LESC can secrete growth factor-like peptides which
migrate through the gel micro-architecture to mediate regenera-
tion of the damaged corneal surface.
There is little available evidence that cell-cell interactions of
transplanted cells drive the healing process. Daya et al. (2005)
[8] indicated that transplanted LESC may not be incorporated
into the exposed, de-epithelialised corneal stromal bed after
transplantation. Instead, an established body of evidence
demonstrates that corneal wound healing is heavily dependent
on growth factors (e.g. epidermal growth factor, keratinocyte
growth factor, hepatocyte growth factor) produced by resident
differentiated epithelial cells and stromal keratocytes [9-11]
(Figure 1). Therefore proteins secreted by LESC may be
responsible for facilitating epithelial repair. This suggests that
studying the secretome of LESC may hold the key to elucidating
the mechanism of corneal reparation.
The therapeutic importance of the stem cell secretome has
recently been highlighted in a number of studies. Specifically,
factors released from progenitor cells were reported to benefi-
cially modulate degenerative conditions. For example, mesen-
chymal stem cell (MSC)-derived molecules were demonstrated
to mediate angiogenesis [12–13]. Furthermore, trophic and
immunomodulatory cytokines secreted from MSC were report-
ed to reverse hepatic failure [14] and were shown to be a
potentially effective treatment for ischaemic heart disease [15],
as well as regeneration of the central nervous system [16].
Trophic effects of adipose stem cell (ASC) secreted factors (e.g.
granulocyte and macrophage colony stimulating factors, inter-
leukins, adipokines) are also protective, and they induce cell
differentiation and immunomodulatory effects on a range of
endogenous cells/tissues [17]. The ASC secretome is known to
impact on the immune and central nervous system, vascular-
PLOS ONE | www.plosone.org 1 July 2013 | Volume 8 | Issue 7 | e70860
ization and cardiac regeneration [17]. Paracrine factors secreted
from ASC were shown to lead to distinct effects on the
metabolic viability and neuronal cell densities in primary
cultures of hippocampal neurons [18]. Effects of the embryonic
stem cell (ESC) secretome are less well-characterised than those
of MSC and ASC, but profiles of proteins secreted during
differentiation of murine ESC were previously reported to be
distinct during cardiomyogenesis and neurogenesis [19].
Considering this evidence, in the present study we demonstrate
that the conditioned medium generated from primary human
LESC immobilized in alginate gels significantly attenuated the
proliferation of corneal epithelial cells. We show distinct protein
banding patterns between alginate-encapsulated and isolated
LESC that highlight differences between proteins at approximate-
ly 35, 38, 43 and 55 kDa. We identified secreted proteins that have
been reported to both drive (profilin-1 - 12 kDa and galectin-1 –
12–15 kDa) and inhibit (sPARC – 43 kDa) proliferation of
epithelial cells. To our knowledge, this is the first study to
examine the secretome of LESC.
This research indicates that a pharmacological approach to the
treatment of LSCD may be devised by employing the factors that
they secrete rather than the cells per se, and that this may
eliminate the problems with variability encountered with current
therapy for this condition.
Materials and Methods
Ethics Statement
Corneoscleral rims were obtained from human cadavers from
the Royal Berkshire Hospital following corneal transplants, and
used for experiments with approval from the University of
Reading Research Ethics Committee. Informed, written consent
from the donor or the next of kin was obtained for use of these
samples in research.
Materials
Antibiotics (penicillin/streptomycin, amphotericin B), What-
man chromatography paper, Trypan Blue, Tris-base, acrylam-
ide, acutase, acetic acid, polyvinylidine difluoride (PVDF)
membrane and methanol were purchased from Thermo
Scientific HyClone (Fisher Scientific: Leicestershire, UK).
CnT20 medium was obtained from CellnTec (Advanced Cell
Systems: Buckingham, UK). Sodium alginate (viscosity: 15-
20 cP, 1% in H2O (lit.)), calcium chloride, sodium citrate and
sodium chloride were from (Sigma-Aldrich: Poole, UK).
TweenH-20, sodium dodecyl sulphate (SDS), 2-mercaptoetha-
nol, ammonium persulphate (AMPS), N,N,N’,N’-tetramethy-
lethylenediamine (TEMED), ethylenediaminetetraacetic acid
(EDTA), 2-[2-(4-nonylphenoxy)ethoxy]ethanol (igepal - nonidet
P40 (NP40)), phenylmethanesulphonyl fluoride (PMSF), apro-
tinin, leupeptin, sodium orthovanadate, pepstatin A, silver
nitrate, sodium carbonate, sodium acetate, and sodium
thiosulphate were also purchased from Sigma. The immortal-
ized human corneal epithelial (HCE) cell-line was from
RIKEN BioResource Center (Tsukuba, Ibaraki, Japan) and
the human corneoscleral rims were kindly donated by the
Royal Berkshire Hospital (Dr Martin Leyland) following cornea
transplantations. The enhanced chemiluminescence (ECL)
detection system was obtained from Pierce (Thermo Fisher
Scientific; Rockford, IL USA). The 14-3-3f antibody was from
Santa Cruz Biotechnology (Autogen Bioclear Ltd.: Calne,
Wilts, UK), the p63 antibody was purchased from Millipore
(Dundee, Scotland). sPARC and profilin-1 antibodies were
from New England Biolabs (Cell Signaling technology:
Hertfordshire, UK). Horseradish peroxidase (HRP)-conjugated
anti-rabbit and anti-goat secondary antibodies, galectin-1
antibodies were from R&D systems (Abingdon, UK) and
bovine serum albumin was obtained from First Link (Birming-
ham, UK).
Figure 1. Corneal wound healing. A number of growth factors and cytokines are released following epithelial injury in the cornea. These factors
mediate the epithelial-stromal interactions that are critical for wound healing. Keratinocyte growth factor (KGF) and hepatocytes growth factor (HGF)
are produced by stromal keratocytes, and interleukin-1 (IL-1) and platelet-derive growth factor (PDGF) are secreted by epithelial cells to regulate
stromal responses to injury. Epidermal growth factor (EGF), IGF and transforming growth factor b (TGF-b) play roles in both epithelium and stromal
repair. Cross-talk between these factors ultimately determines the outcome of corneal wound healing.
doi:10.1371/journal.pone.0070860.g001
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Methods
Isolation of human limbal epithelial cells. LESC were
isolated from human corneoscleral rims. Briefly, explants were
cultured in CnT20 medium, LESC outgrowths from explants were
detached from tissue culture plants using acutase, and these cells
were counted before encapsulation in alginate gels.
Production of Conditioned Medium from Alginate-
Encapsulated LESC. 36105 primary LESC were suspended
in 1.2% w/v sodium alginate solution (420 mL) before gelling into
discs as previously described [20] using 102 mM CaCl2. Briefly, to
form gel discs, a paper ring with a 2 cm diameter opening was
placed over a 3 cm diameter paper disc, and saturated with
102 mM CaCl2 before pipetting 420 mL alginate solution into the
ring (Figure 2). A second 3 cm diameter paper disc saturated with
102 mM CaCl2 was placed over the alginate/paper assembly.
Alginate solutions were exposed to 102 mM CaCl2 for 10 min to
allow complete gelation. Calcium alginate discs with or without
LESC were suspended in CnT20 medium under and cultured at
37uC, 5% CO2, 95% humidity for 3 days.
Conditioned medium (CM) was prepared from both alginate-
encapsulated and non-encapsulated LESC ((36105) cultured on
tissue culture plastic in CnT20 for 3 days). After the 3-day culture
period, CM from alginate-encapsulated and non-encapsulated
LESC was collected and centrifuged at 15500 g for 10 min to
remove cellular debris. The supernatant was retained and the
pellet discarded. CM generated from individual corneoscleral rims
was not pooled and each sample represented a separate biological
replicate.
Culture of a human corneal epithelial cell-line in LESC
conditioned medium. The human corneal epithelial (HCE)
cell-line [21] (referred to as corneal epithelial cells: CEC) was
cultured in CMALG-LESC and CMLESC on tissue culture plastic for
approximately 3 days to monitor the ability of these cells to attach,
form colonies and proliferate. CnT20 medium incubated with
alginate gels alone (CMALG), CnT20 cultured without cells
(CMCULT), and non-cultured CnT20 (CMNON-CULT) were used
to culture CEC as experimental controls. CEC were isolated from
culture medium after the 3-day culture period, and the Trypan
blue exclusion assay was performed to assess cell viability and
proliferation. A 10 mL cell suspension was mixed with 10 mL
Trypan blue dye solution, before counting live (unstained) and
dead (stained-blue) cells using a haemocytometer.
One Dimensional Gel Electrophoresis. Sodium dodecyl
sulphate - polyacrylamide gel electrophoresis (SDS-PAGE) was
carried out in discontinuous vertical slab gels which contained a
final concentration of 15% v/v acrylamide in the resolving gel and
4% (v/v) acrylamide in the stacking gel. The stacking gel
contained stacking gel buffer (0.5 M Tris-base; pH 6.8), 30% (v/
v) acrylamide, 10% (w/v) SDS, 0.05% (v/v) TEMED and 1.5%
(w/v) AMPS. The resolving gel comprised resolving gel buffer
(3 M Tris-base and 5 N HCl; pH 8.8), 30% (v/v) acrylamide,
10% (w/v) SDS, 0.08% (v/v) TEMED and 1.5% (w/v) AMPS.
The amount of total protein in LESC lysates and CM samples was
quantified using the modified Lowry protein assay, and samples
were prepared by addition of an equal volume of Laemmli
reducing sample-treatment buffer (RSTB: 4% (w/v) SDS, 10% (v/
v) 2-mercaptoethanol, 20% (v/v) glycerol, 0.5 M Tris-base and
0.001% (w/v) bromophenol blue) to solutions of lysed cells and
CM (1 1). RSTB-treated samples (10 mg total protein per sample)
were loaded onto the stacking gel and separated in resolving gels
using 100 V per gel. Gels were then either silver stained or
immunoblotted.
Silver nitrate protein staining
Proteins from LESC CM were stained with silver nitrate.
Briefly, proteins immobilized in 15% v/v acrylamide gels were
fixed in a solution containing 40% (v/v) methanol, 10% (v/v)
acetic acid and 50% (v/v) water. Gels were then washed 3 times
for 5 min each time before proteins were sensitized (5% (w/v)
sodium thiosulphate, 30% (v/v/) ethanol and 68 mg/mL sodium
acetate) for 30 min. The gel was then washed 3 times with
deionised water for 10 min each time, and stained with 2.5% (w/v)
silver nitrate for 20 min. Stained gels were washed twice with
deionised water (2 min per wash, and the silver stain was
developed using a solution of 2.5% (w/v) sodium carbonate and
0.04% (v/v) formaldehyde. When protein bands were visible,
development of the stain was stopped using a 1.46% (w/v) EDTA-
Na22H2O solution. The stained gels were washed with water
imaged using a GE Healthcare gel scanner densitometer and
ImageQuant software. Gels were stored in 5% (v/v) acetic acid at
4uC.
Immunoblotting
Proteins were transferred from SDS-PAGE gels to PVDF
membranes under semi-dry conditions using 200 V per gel for
2 h. Non-specific binding to membranes was blocked by
incubation with 5% (w/v) bovine serum albumin (BSA)
dissolved in 16 TBS-T (20 mM Tris-base, 0.14 M NaCl,
0.1% TweenH-20; pH 7.6) for 1 h at room temperature.
Membranes were incubated with primary antibodies (anti-
p63 1/8000 dilution), anti-sPARC, anti-galectin-1, and anti-
profilin-1) diluted in 2% (w/v) BSA dissolved in 16 TBS-T at
4uC overnight. b-mercaptoethanol stripping buffer was used to
remove the primary p63 antibody from membranes before an
anti-14-3-3f antibody (1/4000 dilution) was used to detect 14-3-
3f (loading control). Blots were washed for 45 min in 16TBS-T
before incubation with HRP-conjugated anti-rabbit (1 4000
dilution) secondary antibody for 2 h at room temperature with
rotation. Proteins were detected on X-ray film using an ECL
system; the film was exposed to membranes for 5–10 seconds to
capture protein/ECL signals.
Figure 2. Schematic of LEC encapsulation in alginate gels. To
form alginate gel discs, a paper ring with a 2 cm diameter opening is
placed over a 3 cm diameter paper disc, and saturated with 102 mM
CaCl2 before alginate solution (420 mL) was pipetted into the ring. A
second 3 cm diameter paper disc saturated with 102 mM CaCl2 was
placed over the alginate/paper assembly. Alginate solutions were
exposed to 102 mM CaCl2 for 10 min to allow complete gelation.
Dimensions of calcium alginate gel masses and discs. Calcium alginate
gel discs are approximately 19 mm in length and 1.5 mm in depth.
doi:10.1371/journal.pone.0070860.g002
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Statistical Analysis
Unpaired t-tests were performed using Microsoft Excel to
determine the statistical significance between CEC proliferation in
conditioned medium from alginate-encapsulated and non-encap-
sulated LESC. Results are presented as the mean of three
individual experiments with standard error of mean (S.E.M.) and
P-value#0.05 considered significant.
Results and Discussion
Corneal epithelial cell proliferation is modulated by CM
from alginate-encapsulated LESC
We have previously demonstrated that calcium alginate gels are
suitable for storage/transport of immobilized embryonic stem
cells, mesenchymal stem cells, and LESC [20,22], proving that
these 3-D matrices are capable of retaining the progenitor
phenotype of encapsulated cells.
To determine the influence of the alginate gel matrix on the
production of potential corneal wound healing factors from LESC,
we examined the ability of CEC to proliferate in CM generated
from alginate-encapsulated LESC (CMALG-LESC) (Figure 3).
Proliferation of CEC was attenuated significantly (P#0.05) (.2
fold) in undiluted CM from CMALG-LESC compared to CEC
cultured in CM from non-encapsulated LESC (CMLESC). The
addition of CnT20 to CMALG-LESC and CMLESC increased CEC
proliferation, but CEC growth remained significantly lower in
CMALG-LESC. This indicated that despite the inclusion of growth
promoting factors from CnT20 medium, inhibition of CEC
growth in CMALG-LESC was not completely reversed.
The proliferation of CEC in CMALG was less pronounced than
CEC proliferation in cultured CnT20 (CMCULT) or non-cultured
CnT20 (CMNON-CULT). The basal media CnT20 contains factors
known to promote CEC proliferation, therefore the decrease in
proliferation of CEC in CMALG compared to CMCULT or
CMNON-CULT may be due to the sequestering of factors from
CnT20 medium by the alginate gel that we have shown is capable
of adsorbing proteins from medium solutions (Table S1). Protein
levels were significantly greater (P#0.05) in alginate gels suspend-
ed in CnT20 medium with supplements (9760.007 mg/mL) than
those suspended in basal medium (7560.004 mg/mL) (Table S1).
Protein adsorption to alginate hydrogels was previously reported
[23]. Therefore, diluting the CMALG with fresh CnT20 partially
replenishes some of the growth factors explaining the moderate
increase in proliferation. Interestingly, CEC proliferation in
CMALG-LESC, was significantly lower (P#0.01) than that from
CMALG, strongly suggesting that either a factor inhibitory to
proliferation was produced by encapsulated LESC or that
expression and/or release of factors required for promoting
CEC proliferation were prevented by the 3D gel structure.
Figure 3. LESC conditioned medium modulates corneal epithelial cell proliferation. Data points represent the mean (n = 36S.E.M.)
number live cells extracted. * P#0.05 indicate differences between culture conditions.
doi:10.1371/journal.pone.0070860.g003
Figure 4. Profiles of secreted proteins from alginate-encapsu-
lated and cultured LESC are distinct. Conditioned medium from
alginate-encapsulated LESC (CMALG-LESC), LESC cultured in CnT20
(CMLESC), alginate gels alone (CMALG), cultured CnT20 (CMCULT), and
non-cultured CnT20 (CMNON-CULT) were treated with Laemmli buffer
containing the reducing agent b-mercaptoethanol. Treated protein
mixtures were separated using 15% acrylamide gels and proteins were
stained using silver nitrate. Gel represents 3 individual experiments
from 3 different corneoscleral rims.
doi:10.1371/journal.pone.0070860.g004
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Previously we reported that the proliferation of LESC
immobilized in alginate gels is limited or prevented [20]. This
was possibly due to mechanical forces exerted on encapsulated
LESC, i.e. cells are physically prevented from growing (possibly
due to pore sizes which were significantly smaller than the size of
cells or inappropriate levels of gel stiffness); an increase in the
compressive modulus of alginate gels decreased the viability of
immobilized cells [20]. Studies have shown that the movement of
small-molecules through alginate gels is controlled by the internal
structure of these matrices [24]. Increasing alginate concentration
from 1.5% to 3%, decreasing intrinsic pore size, was previously
shown to hinder the movement of various solutes through this gel.
Therefore, an alternative explanation may be that factors required
for proliferation of CEC are released too slowly from alginate gels.
The release of proteins or peptides from alginate encapsulated
LESC may be dependent on their size, with larger proteins
migrating at a slower rate through gels than peptides of relatively
lower molecular mass.
Taken together the data presented here suggest that LESC
encapsulated in an alginate gel matrix secrete factors that can
attenuate the growth of a secondary cell population.
Proteins that regulate epithelial cell proliferation are
identified within the LESC secretome
To determine the possibility that factors secreted from LESC
may be responsible for the observed inhibitory effect on CEC
proliferation, we performed biochemical characterisation of
CMALG-LESC.
Examination of the LESC secretome by 1-D gel electrophoresis
and silver staining resolved distinct protein banding patterns from
CMALG-LESC and CMLESC (Figure 4). The amount of total
protein loaded onto gels were equivalent to 10 mg for each sample,
therefore differences observed between samples are not biased by
unequal protein loading. Proteins (indicated on Figure 4 with
arrows) ranging from approximately 35–55 kDa were expressed at
lower levels in CMALG-LESC than from CMLESC. At lower molecular
weights 30–20 kDa protein bands from both CMALG-LESC and
CMLESC, are expressed to similar levels. Proteins included into
CnT20 medium as supplementary factors (approximately 55 –
80 kDa) were expressed to greater levels in CMALG, than in
CMCULT or CMNON-CULT, suggesting that medium proteins
within the CnT20 basal media may be both concentrated and
adsorbed (see Figure 3) by alginate gels.
We hypothesise that proteins ranging from approximately 35–
55 kDa which varied in levels due to encapsulation within alginate
gels may elicit effects on epithelial cell growth. We used previous
studies investigating the secretome of epithelial cells from non-
pigmented ciliary [25] and mammary tissue [26] as mining
references for proteins of potential relevance to corneal wound
healing. The secretome of non-pigmented ciliary epithelium was of
particular interest as this group of proteins was studied as
candidate factors for promoting differentiation and growth of
retinal ganglion cells [25]. Based on this study we focused on
identifying thrombospondin 1, galectin-1, secreted protein, acidic
and rich in cysteine (sPARC), cofilin-1, profilin-1, and myotrophin
in CMALG-LESC, as these proteins play important roles in cell
proliferation and/or differentiation.
We identified by Western blotting, sPARC, profilin-1, and
galectin-1 in the CMALG-LESC and CMLESC (Figure 5). Samples
were equally loaded: 10 mg total protein from CMLESC-ALG and
CMLESC were loaded separately onto gels. sPARC (Figure 5A), a
43 kDa protein (see 43 kDa band indicated on Figure 4), that was
identified in CMLESC-ALG and CMLESC was particularly interest-
ing due to well-characterised functions as a growth factor
modulator and cell cycle inhibitor [27]. sPARC may therefore,
Figure 5. Proteins known to modulate cell proliferation are identified within the LESC secretome. SPARC (A), galectin 1 (B), and profilin 1
(C) were detected in conditioned medium from alginate-encapsulated LESC (CMALG-LESC) and LESC (CMLESC) cultured in CnT20 for 3 days under cell
culture conditions by immunoblotting. Blots represent 3 individual experiments from 3 different corneoscleral rims.
doi:10.1371/journal.pone.0070860.g005
Figure 6. Cultured LESC retain a progenitor phenotype. P63 was
detected in freshly isolated LESC (control: C), alginate-encapsulated
LESC (Alg) and LESC cultured (Cult) in CnT20 for 3 days under cell
culture conditions by immunoblotting. 14-3-3f was used as a loading
control. Blots represent 3 individual experiments from 3 different
corneoscleral rims.
doi:10.1371/journal.pone.0070860.g006
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be responsible, at least in part, for the marked inhibition of CEC
proliferation in CMLESC-ALG. However, the greater proliferation
of CEC in CMLESC than CMALG-LESC may be due to galectin-1
(Figure 5B) that induces cell proliferation [28]. This protein
was highly expressed in CMLESC but was not expressed in
CMALG-LESC.
Encapsulated LESC expressed the progenitor marker, p63,
(Figure 6) to lower levels than cultured LESC indicating that
these cells were potentially undergoing differentiation within
alginate gels. Profilin-1 (Figure 5C) that was shown to be secreted
by CMALG-LESC was recently demonstrated as an essential element
for the differentiation of human epithelial cells [29]. Alginate-
encapsulated LESC may be at various stages of differentiation
dependent on surrounding levels of profilin-1. Although the
secreted lectin, galectin-1 (Figure 5B) was not identified in
CMALG-LESC, this protein may also drive differentiation of corneal
epithelial cells.
sPARC may regulate the differentiation of epithelial cells as well
as the inhibition of these cells during corneal wound healing.
Disruption of the sPARC locus in mice with sPARC-null lens
resulted in altered lens development manifested by changes in
epithelial cell differentiation [30]. sPARC was reported to be
secreted from corneal epithelial cells, but this protein was only
shown to regulate the contraction of keratocytes embedded in
collagen gels [31]. Similar to our study, this study confirmed using
Western blot analysis that sPARC was contained in epithelial cell
conditioned medium. The authors reported that collagen gel
contraction by keratocytes with increased contractility due to
addition of purified sPARC was enhanced in a dose-dependent
manner. Furthermore, sPARC was identified in the basal layer of
the migrating epithelium and activated keratocytes adjacent to the
wound 3 days and 1 week after perforating injury in rabbit
corneas.
sPARC-mediated mechanisms for inhibition of CEC prolifer-
ation may involve inhibition of IGF-dependent signalling [10] and
stimulation of the TGF-b signalling pathway [32] both at the
receptor level and within cells. sPARC has been reported to inhibit
epithelial cell proliferation by stimulating the TGF-b signalling
system [32], and this effect is corrobated by the Mishima et al.
(1998) [31] study that describes a direct effect of sPARC on
fibroblasts, i.e. scar contraction. As TGF-b transforms stromal
keratocytes into myofibroblasts that are the primary mediators of
scar formation [11], it is thought that reducing levels of sPARC in
the cornea could limit or eliminate scar formation and enhance
closure of corneal epithelial wounds.
Reports showing sPARC inhibition of IGF signalling demon-
strated that sPARC-null mesangial cells producing increased
amounts of IGF-1 and -2, as well as IGF-1 receptor (IGF-1R) were
attenuated by the addition of recombinant sPARC [10]. The
secreted protein inhibited sPARC-null cells by blocking IGF-1-
stimulated mitogen activated protein kinase (MAPK) activation
and DNA synthesis. An accelerated rate of basal and IGF-1-
stimulated proliferation in mesangial cells derived from sPARC-
null animals was shown to be partially due to significantly
diminished levels of cyclin D1 and the cyclin-dependent kinase
(CDK) inhibitors p21 and p27. As IGF signalling in the cornea
stimulates epithelial cell proliferation [33], sPARC is likely to play
dual complementary roles in corneal wound healing that
culminate in inhibition of epithelium turnover and reinforcement
of scar tissue.
A working model (Figure 7) of novel wound healing processes
in the cornea could be developed, demonstrating that sPARC
affects intracellular events downstream of TGF-b and IGF
receptors by directly targeting these membrane proteins and
subsequently downstream signalling proteins within cells including
ERK, PI3K and Akt as well as cell cycle regulator, cyclin D1.
Figure 7. A working model of LEC secretome mechanisms for the modulation of epithelial cell proliferation. SPARC may inhibit corneal
epithelial cell proliferation by targeting IGF, TGF-b and Smad2/3 signalling that is established in corneal wound healing. In the corneal epithelium,
sPARC may inhibit the IGF receptor and activate the TGF-b. Inhibition of epithelium turnover may occur through sPARC-mediated attenuation of
extracellular regulated kinase (ERK), phosphoinositide-3-kinase (PI3K) and Akt in the cytoplasm leading to reduction in the activity of the cell cycle
regulator, cyclin D1 in the nucleus.
doi:10.1371/journal.pone.0070860.g007
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Together, these mechanistic events may be the drivers that
ultimately lead to growth arrest of CEC.
Collectively, these data suggest that the secretome of alginate-
encapsulated LESC may be applied to corneal dysfunctions
requiring control of the growth of epithelium.
Conclusions
We have demonstrated that LESC secrete proteins that exert
powerful effects on corneal epithelial growth. Our alginate gel
matrix allows the secretion of inhibitory proteins from encapsu-
lated LESC that may regulate epithelialisation of the cornea.
Corneal wound healing is complex and stringently regulated, but
we describe findings that indicate the potential for delivering
molecules produced from LESC to modulate repair of the injured
cornea using bioartificial alginate hydrogel systems. These gels are
very accessible for this application, as selection of the type of
alginate and coating agent, the pore size, and gel degradation rate,
would ultimately control release kinetics of cell-derived soluble
factors. Therefore these matrices as bioartificial niche micro-
environments can be applied to clinical distribution of endogenous
LESC-derived proteins in a manner that mimics their physiolog-
ical rate of release. The present study may lead to the discovery of
novel facets of corneal wound healing dynamics that may be
dependent on secreted proteins derived from both terminally-
differentiated and progenitor corneal epithelial cells.
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